In this study, 12 potential methylated sites in the MYCT1 promoter region were predicted in silico, and hypermethylation was observed in 10 LSCC tumor samples and the Hep2 cancer cells by BSP-based sequencing. The gene discussed is MYCT1; the disease is cancer.